Article
Behavioural phenotyping reveals anxiety-like features of SV2A deficient mice.
Behavioural brain research - 17 Mar 2009
Lamberty Yves, Detrait Eric, Leclercq Karine, Michel Anne, De Ryck Marc
Abstract excerpt
Synaptic vesicle protein 2A (SV2A) is involved in neurotransmitter release and has been identified as the binding site for levetiracetam (Keppra), a novel antiepileptic drug. Homozygous SV2A (-/-) mice are not viable beyond a few weeks. In contrast, heterozygous SV2A (+/-) mice have a normal lifespan. We performed a behavioural phenotyping on SV2A (+/-) mice in a battery of tests: gross behavioural observation,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
